nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0365	0.0732	CcSEcCtD
Cefaclor—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0319	0.0665	CbGpPWpGaD
Cefaclor—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.0296	0.0617	CbGpPWpGaD
Cefaclor—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.021	0.042	CcSEcCtD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0205	0.0428	CbGpPWpGaD
Cefaclor—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.02	0.0418	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.0191	0.0397	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0188	0.0392	CbGpPWpGaD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0188	0.0392	CbGpPWpGaD
Cefaclor—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0186	0.0388	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0174	0.0364	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0174	0.0364	CbGpPWpGaD
Cefaclor—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0327	CcSEcCtD
Cefaclor—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.016	0.0321	CcSEcCtD
Cefaclor—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0289	CcSEcCtD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0142	0.0297	CbGpPWpGaD
Cefaclor—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0269	CcSEcCtD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.0132	0.0276	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0132	0.0275	CbGpPWpGaD
Cefaclor—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0251	CcSEcCtD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.0123	0.0256	CbGpPWpGaD
Cefaclor—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0238	CcSEcCtD
Cefaclor—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.0118	0.0246	CbGpPWpGaD
Cefaclor—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.0109	0.0228	CbGpPWpGaD
Cefaclor—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0209	CcSEcCtD
Cefaclor—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0207	CcSEcCtD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00918	0.0191	CbGpPWpGaD
Cefaclor—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00887	0.0178	CcSEcCtD
Cefaclor—Injury—Hydrochlorothiazide—nephrolithiasis	0.00872	0.0175	CcSEcCtD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00852	0.0178	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00839	0.0175	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00839	0.0175	CbGpPWpGaD
Cefaclor—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00804	0.0161	CcSEcCtD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00779	0.0162	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00779	0.0162	CbGpPWpGaD
Cefaclor—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00773	0.0155	CcSEcCtD
Cefaclor—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00751	0.015	CcSEcCtD
Cefaclor—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00721	0.0144	CcSEcCtD
Cefaclor—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00709	0.0142	CcSEcCtD
Cefaclor—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00707	0.0141	CcSEcCtD
Cefaclor—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00692	0.0139	CcSEcCtD
Cefaclor—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00647	0.013	CcSEcCtD
Cefaclor—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00647	0.013	CcSEcCtD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00636	0.0133	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00636	0.0133	CbGpPWpGaD
Cefaclor—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00612	0.0123	CcSEcCtD
Cefaclor—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.006	0.012	CcSEcCtD
Cefaclor—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00592	0.0119	CcSEcCtD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00591	0.0123	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00591	0.0123	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0059	0.0123	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0059	0.0123	CbGpPWpGaD
Cefaclor—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00589	0.0118	CcSEcCtD
Cefaclor—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00582	0.0117	CcSEcCtD
Cefaclor—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00579	0.0116	CcSEcCtD
Cefaclor—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00576	0.0115	CcSEcCtD
Cefaclor—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00556	0.0111	CcSEcCtD
Cefaclor—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00554	0.0111	CcSEcCtD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00549	0.0114	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00549	0.0114	CbGpPWpGaD
Cefaclor—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00546	0.0109	CcSEcCtD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00527	0.011	CbGpPWpGaD
Cefaclor—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00524	0.0105	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00523	0.0109	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00523	0.0109	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00489	0.0102	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00486	0.0101	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00486	0.0101	CbGpPWpGaD
Cefaclor—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00952	CcSEcCtD
Cefaclor—Tension—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00948	CcSEcCtD
Cefaclor—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00469	0.00938	CcSEcCtD
Cefaclor—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00934	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00466	0.00973	CbGpPWpGaD
Cefaclor—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00905	CcSEcCtD
Cefaclor—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00448	0.00896	CcSEcCtD
Cefaclor—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00888	CcSEcCtD
Cefaclor—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00883	CcSEcCtD
Cefaclor—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00871	CcSEcCtD
Cefaclor—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00868	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00433	0.00903	CbGpPWpGaD
Cefaclor—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00866	CcSEcCtD
Cefaclor—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00865	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00427	0.00889	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00427	0.00889	CbGpPWpGaD
Cefaclor—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00426	0.00854	CcSEcCtD
Cefaclor—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00849	CcSEcCtD
Cefaclor—Cough—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00843	CcSEcCtD
Cefaclor—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00822	CcSEcCtD
Cefaclor—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00822	CcSEcCtD
Cefaclor—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00822	CcSEcCtD
Cefaclor—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00409	0.0082	CcSEcCtD
Cefaclor—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00813	CcSEcCtD
Cefaclor—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00397	0.00795	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00396	0.00826	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00396	0.00826	CbGpPWpGaD
Cefaclor—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00788	CcSEcCtD
Cefaclor—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00788	CcSEcCtD
Cefaclor—Shock—Hydrochlorothiazide—nephrolithiasis	0.00387	0.00776	CcSEcCtD
Cefaclor—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00772	CcSEcCtD
Cefaclor—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00762	CcSEcCtD
Cefaclor—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00752	CcSEcCtD
Cefaclor—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00737	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00718	CcSEcCtD
Cefaclor—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00356	0.00713	CcSEcCtD
Cefaclor—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00708	CcSEcCtD
Cefaclor—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00703	CcSEcCtD
Cefaclor—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00701	CcSEcCtD
Cefaclor—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00694	CcSEcCtD
Cefaclor—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00685	CcSEcCtD
Cefaclor—Pain—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00674	CcSEcCtD
Cefaclor—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00674	CcSEcCtD
Cefaclor—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0065	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00323	0.00674	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00323	0.00674	CbGpPWpGaD
Cefaclor—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00645	CcSEcCtD
Cefaclor—SLC15A1—nephron tubule—nephrolithiasis	0.00316	0.15	CbGeAlD
Cefaclor—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00626	CcSEcCtD
Cefaclor—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00623	CcSEcCtD
Cefaclor—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00623	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00301	0.00627	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00301	0.00627	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.003	0.00626	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.003	0.00626	CbGpPWpGaD
Cefaclor—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00581	CcSEcCtD
Cefaclor—SLC15A1—renal system—nephrolithiasis	0.00287	0.136	CbGeAlD
Cefaclor—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00566	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00279	0.00582	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00279	0.00582	CbGpPWpGaD
Cefaclor—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00558	CcSEcCtD
Cefaclor—SLC15A1—kidney—nephrolithiasis	0.00277	0.132	CbGeAlD
Cefaclor—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00539	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00268	0.00559	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00268	0.00559	CbGpPWpGaD
Cefaclor—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00521	CcSEcCtD
Cefaclor—MPO—renal system—nephrolithiasis	0.00258	0.123	CbGeAlD
Cefaclor—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00501	CcSEcCtD
Cefaclor—MPO—kidney—nephrolithiasis	0.0025	0.118	CbGeAlD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00249	0.00518	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00249	0.00518	CbGpPWpGaD
Cefaclor—Rash—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00497	CcSEcCtD
Cefaclor—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00497	CcSEcCtD
Cefaclor—Headache—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00494	CcSEcCtD
Cefaclor—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00468	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00214	0.00447	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00199	0.00414	CbGpPWpGaD
Cefaclor—SLC15A2—nephron tubule—nephrolithiasis	0.00197	0.0936	CbGeAlD
Cefaclor—SLC15A2—renal system—nephrolithiasis	0.00179	0.0851	CbGeAlD
Cefaclor—SLC15A2—kidney—nephrolithiasis	0.00173	0.0823	CbGeAlD
Cefaclor—SLC15A2—cortex of kidney—nephrolithiasis	0.00169	0.0801	CbGeAlD
